India to Malta: Letrozole Export Trade Route

The India to Malta Letrozole corridor is one of India's established pharmaceutical export routes, with 132 shipments documented worth a combined $504.2K USD. The route is dominated by EUGIA PHARMA SPECIALITIES LIMITED, which alone accounts for roughly 80% of all export value, reflecting the consolidated nature of India's letrozole manufacturing sector.

Across 6 active suppliers, the average shipment value stands at $3.8K USD — a figure that reflects both bulk commercial orders from large pharmaceutical companies and smaller specialty shipments. Sea freight dominates at 76% of all shipments, consistent with letrozole's non-urgent bulk-order profile.

Shipment activity peaks during January–March, with an average transit time of 27 days port-to-port. The route has recorded an annual growth rate of 13.8%, placing it at rank #18 among India's top letrozole export destinations globally.

On the import side, key buyers of Indian letrozole in Malta include EUGIA PHARMA (MALTA) LTD,, EUGIA PHARMA MALTA LIMITED, EUGIA PHARMA (MALTA) LTD and 11 others. EUGIA PHARMA (MALTA) LTD, is the single largest importer with 18 shipments valued at $113.3K USD.

India's letrozole exports to Malta are driven primarily by a handful of large-scale manufacturers. EUGIA PHARMA SPECIALITIES LIMITED with 55 shipments leads the pack, a pattern common in generic pharmaceutical corridors where manufacturing scale creates significant cost advantages. The presence of 6 active exporters signals a competitive but concentrated market — buyers in Malta benefit from supplier diversity while the top tier handles the majority of volume.

The top 3 suppliers — EUGIA PHARMA SPECIALITIES LIMITED, HETERO LABS LIMITED, EUGIA PHARMA SPECIALITIES LIMITED — together account for 100% of total trade value on this route. The average shipment value of $3.8K USD reflects a mix of bulk commercial orders and smaller specialty shipments.

Beyond the primary product category, shipments on this route include closely related formulations such as letrozole 2.5mg tablets (10x10's) and letrozole tablets 2.5mg(letrozole 2.5mg , suggesting that buyers in Malta tend to consolidate orders across related product lines from the same Indian supplier.

On the buying side, EUGIA PHARMA (MALTA) LTD, is the largest importer with 18 shipments worth $113.3K USD — representing 22% of all letrozole imports from India on this route. A total of 14 buyers are active on this corridor.